308 related articles for article (PubMed ID: 8900758)
1. Recombinant human erythropoietin treatment of anemic cancer patients.
Henry DH
Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin therapy in cancer patients.
Doweiko JP; Goldberg MA
Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related anemia: its causes and characteristics.
Spivak JL
Semin Oncol; 1994 Apr; 21(2 Suppl 3):3-8. PubMed ID: 8202724
[TBL] [Abstract][Full Text] [Related]
4. EPO in cancer anemia: benefits and potential risks.
Milano M; Schneider M
Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of recombinant erythropoietin in anemic cancer patients.
Henry DH
Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.
Henry DH
Semin Hematol; 1993 Oct; 30(4 Suppl 6):12-6. PubMed ID: 8153671
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
9. Cancer-related anemia: clinical review and management update.
Hurter B; Bush NJ
Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
12. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of anemia in patients with tumors].
Tesarová P; Kvasnicka J
Cas Lek Cesk; 1995 Oct; 134(20):647-50. PubMed ID: 7489579
[TBL] [Abstract][Full Text] [Related]
14. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
15. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
Lundin AP
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
[TBL] [Abstract][Full Text] [Related]
16. Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.
Beguin Y
Haematologica; 2002 Nov; 87(11):1209-21. PubMed ID: 12414352
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
18. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
19. Anemia therapy: individual benefit and societal cost.
Denton TA; Diamond GA; Matloff JM; Gray RJ
Semin Oncol; 1994 Apr; 21(2 Suppl 3):29-35. PubMed ID: 8202723
[TBL] [Abstract][Full Text] [Related]
20. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
[No Abstract] [Full Text] [Related]
[Next] [New Search]